Acetaminophen-induced hepatotoxicity predominantly via inhibiting Nrf2 antioxidative pathway and activating

Xing-Ling Shen1, Yan-Na Guo1, Meng-Han Lu1

  • 1School of Life Science and Engineering, Foshan University, Foshan 528225, China.

Insights

Acetaminophen (APAP) causes liver injury by inhibiting the Nrf2 antioxidant pathway and activating inflammatory pathways like TLR4-NF-κB-MAPK and NLRP3 inflammasome. This study details the molecular mechanisms and timing of APAP-induced hepatotoxicity.

Area of Science:

  • Hepatology
  • Toxicology
  • Molecular Biology

Background:

  • Acetaminophen (APAP) is a common analgesic with potential for drug-induced liver injury (DILI).
  • Understanding the precise molecular mechanisms and temporal progression of APAP-induced hepatotoxicity is crucial for developing effective interventions.

Purpose of the Study:

  • To elucidate the action time and molecular mechanisms of acetaminophen (APAP) in causing liver injury.
  • To investigate the role of oxidative stress, inflammatory pathways, and inflammasome activation in APAP-induced hepatotoxicity.

Main Methods:

  • Establishment of a DILI model in mice using APAP (300 mg/kg).
  • Assessment of liver injury markers (ALT, AST, ALP), histopathology, oxidative stress (SOD, GSH, MDA), and protein expression via Western blot at 6, 12, and 24 hours post-APAP administration.
  • Analysis of key signaling pathways including Nrf2, NLRP3 inflammasome, TLR4, NF-κB, and MAPKs.

Main Results:

  • APAP exposure led to significant liver damage, characterized by altered liver texture, inflammation, necrosis, and apoptosis.
  • Serum enzyme levels (ALT, AST, ALP) and pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) were significantly elevated at 12 hours.
  • APAP induced oxidative stress by reducing SOD and GSH, increasing MDA, inhibiting the Nrf2/HO-1 pathway, and activating the NLRP3 inflammasome and TLR4-NF-κB-MAPK signaling cascades.

Conclusions:

  • APAP-induced hepatotoxicity is a time-dependent process, with significant molecular and pathological changes evident by 12 hours.
  • The mechanism involves the suppression of the Nrf2 antioxidative pathway and the promotion of inflammatory responses via TLR4-NF-κB-MAPK and NLRP3 inflammasome activation.
  • These findings provide critical insights into the molecular pathogenesis of APAP-induced liver injury.